Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer’S Disease Publisher



Noori M1 ; Khalili Ghomi M2 ; Dastyafteh N1 ; Oliyaei N3 ; Hamedifar H4, 5 ; Javanshir S1 ; Tanideh N3 ; Sattarinezhad E6 ; Sattari F7 ; Haghani M10 ; Rahmani H8 ; Larijani B2 ; Mahdavi M2 ; Hajimiri MH4, 5 Show All Authors
Authors
  1. Noori M1
  2. Khalili Ghomi M2
  3. Dastyafteh N1
  4. Oliyaei N3
  5. Hamedifar H4, 5
  6. Javanshir S1
  7. Tanideh N3
  8. Sattarinezhad E6
  9. Sattari F7
  10. Haghani M10
  11. Rahmani H8
  12. Larijani B2
  13. Mahdavi M2
  14. Hajimiri MH4, 5
  15. Iraji A9
Show Affiliations
Authors Affiliations
  1. 1. Pharmaceutical and Heterocyclic Chemistry Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1416634793, Iran
  3. 3. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, 71348-14336, Iran
  4. 4. CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, 1461965381, Iran
  5. 5. CinnaGen Research and Production Co., Alborz, 3164819712, Iran
  6. 6. Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348-14336, Iran
  7. 7. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, 71348-14336, Iran
  8. 8. Department of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, 1416634793, Iran
  9. 9. Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, 7134845794, Iran
  10. 10. Department of Physiology, The Medical School, Shiraz University of Medical Sciences, Shiraz, 71348-14336, Iran

Source: ACS Omega Published:2024


Abstract

An Isoindolinedione-benzamide pyridinium derivatives were designed through a structure-based strategy and synthesized as novel multifunctional anti-Alzheimer agents. The inhibitory activities of all 17 derivatives against acetylcholinesterase and butyrylcholinesterase were evaluated. Results exhibited that compound 7j displayed promising AChE inhibitory activity with an IC50 value of 0.26 ± 0.07 μM, and compound 7c exhibited an IC50 value of 0.08 ± 0.01 μM against BChE with 132-fold better inhibitory activity in comparison with positive control. Next, the enzyme kinetics studies and detailed binding mode via molecular docking were performed for the most potent compounds. Additionally, molecular dynamics simulations were accomplished to further investigate the potent compound’s interaction, orientation, and conformation over the related enzymes. The neurotoxicity of the most potent derivative was executed against SH-SY5Y, and the mRNA levels of GSK-3α and GSK-3β after treatment with 7c on SH-SY5Y were evaluated. Results exhibited the mRNA levels of GSK-3β were decreased compared to the control group. All these results indicate that 7c is a good starting point for developing a multifunctional anti-Alzheimer compound. © 2024 The Authors. Published by American Chemical Society.
Related Docs
View other Related Docs
1. Synthesis and Evaluation of Novel Arylisoxazoles Linked to Tacrine Moiety: In Vitro and in Vivo Biological Activities Against Alzheimer’S Disease, Molecular Diversity (2022)
2. Design and Synthesis of New 1,2,3-Triazole-Methoxyphenyl-1,3,4-Oxadiazole Derivatives: Selective Butyrylcholinesterase Inhibitors Against Alzheimer’S Disease, BMC Chemistry (2025)
3. Synthesis, Biological Evaluation and Molecular Modeling Studies of Methyl Indole-Isoxazole Carbohydrazide Derivatives As Multi-Target Anti-Alzheimer’S Agents, Scientific Reports (2024)
4. Phenyl-Quinoline Derivatives As Lead Structure of Cholinesterase Inhibitors With Potency to Reduce the Gsk-3Β Level Targeting Alzheimer's Disease, International Journal of Biological Macromolecules (2023)
5. N-Cyclohexylimidazo[1,2-A]Pyridine Derivatives As Multi-Target-Directed Ligands for Treatment of Alzheimer's Disease, Bioorganic Chemistry (2020)
6. Recent Developments in the Design and Synthesis of Benzylpyridinium Salts: Mimicking Donepezil Hydrochloride in the Treatment of Alzheimer’S Disease, Frontiers in Chemistry (2022)
7. Design and Synthesis of Multi-Target Directed 1,2,3-Triazole-Dimethylaminoacryloyl-Chromenone Derivatives With Potential Use in Alzheimer's Disease, BMC Chemistry (2020)
8. Anticholinesterase Activities of Novel Isoindolin-1,3-Dione-Based Acetohydrazide Derivatives: Design, Synthesis, Biological Evaluation, Molecular Dynamic Study, BMC Chemistry (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Mahdavi (11)
Mina Saeedi (9)
Other Related Docs
9. Synthesis and Bio-Evaluation of New Multifunctional Methylindolinone-1,2,3-Triazole Hybrids As Anti-Alzheimer's Agents, Journal of Molecular Structure (2021)
10. Cinnamic Acid Conjugated With Triazole Acetamides As Anti-Alzheimer and Anti-Melanogenesis Candidates: An in Vitro and in Silico Study, Scientific Reports (2025)
11. Novel Aryl(4-Phenylpiperazin-1-Yl)Methanethione Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro and in Silico Assays, Journal of Molecular Structure (2022)
12. Amino-7,8-Dihydro-4H-Chromenone Derivatives As Potential Inhibitors of Acetylcholinesterase and Butyrylcholinesterase for Alzheimer’S Disease Management; in Vitro and in Silico Study, BMC Chemistry (2024)
13. Novel Tacrine-1,2,3-Triazole Hybrids: In Vitro, in Vivo Biological Evaluation and Docking Study of Cholinesterase Inhibitors, European Journal of Medicinal Chemistry (2017)
14. Aminoimidazo[1,2-A]Pyridine Bearing Different Pyrazole Moieties As the Structural Scaffold for the Development of Bace1 Inhibitor; Synthesis, Structural Characterization, in Vitro and in Silico Studies, Current Organic Synthesis (2022)
15. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated With Alzheimer's Disease, Chemistry and Biodiversity (2020)